Clinical Trials Directory

Trials / Unknown

UnknownNCT00285441

Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (planned)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify differences in TB specific immune responses among immunosuppressed patients latently infected with TB and patients with active TB.

Detailed description

Immunosuppressed patients latently infected with TB are at higher risk of developing active TB than patients with normal immune functions. Especially two patient categories are at risk: HIV positives and patients receiving TNF-a blocking medication. Existing methods of diagnosis and surveillance of latent TB infection can not identify who will develop active TB and who can control the infection. There is a need for better understanding of TB specific immune functions,as we believe deficient TB specific immune reactions is a key in reactivation of latent TB infection. In this study we follow groups of latent TB infected patients with either rheumatoid arthritis or HIV. We follow the patients during treatment with TNF-a blocking medication, HAART treatment or prophylactic TB medication. Results are correlated to patients with active TB, latent TB and healthy controls.

Conditions

Timeline

Start date
2005-11-01
Completion
2008-09-01
First posted
2006-02-02
Last updated
2006-02-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00285441. Inclusion in this directory is not an endorsement.

Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tube (NCT00285441) · Clinical Trials Directory